MatikainenN, PekkarinenT, RyhänenEM, and Schalin-JänttiC. (2021). Physiology of calcium homeostasis: an overview. Endocrinol Metab Clin North Am, 50:575–590.
2.
MingioneA, VerdelliC, TerranegraA, SoldatiL, and CorbettaS. (2015). Molecular and clinical aspects of the target therapy with the calcimimetic cinacalcet in the treatment of parathyroid tumors. Curr Cancer Drug Targets, 15:563–574.
3.
KamedaY. (2023). Cellular and molecular mechanisms of the organogenesis and development, and function of the mammalian parathyroid gland. Cell Tissue Res, 393:425–442.
4.
YamadaT, TatsumiN, AnrakuA, SuzukiH, KamejimaS, UchiyamaT, OhkidoI, YokooT, and OkabeM. (2019). Gcm2 regulates the maintenance of parathyroid cells in adult mice. PLoS ONE, 14(1):e0210662.
5.
VerdelliC, MorottiA, TavantiGS, SilipigniR, GuerneriS, FerreroS, VicentiniL, VairaV, and CorbettaS. (2021). The core stem genes SOX2, POU5F1/OCT4, and NANOG are expressed in human parathyroid tumors and modulated by MEN1, YAP1, and β-catenin pathways activation. Biomedicines, 9:637.
6.
CorbettaS, BelicchiM, PisatiF, MeregalliM, Eller-VainicherC, VicentiniL, Beck-PeccozP, SpadaA, and TorrenteY. (2009). Expression of parathyroid-specific genes in vascular endothelial progenitors of normal and tumoral parathyroid glands. Am J Pathol, 175:1200–1207.
7.
FangSH, GuidrozJA, O'MalleyY, LalG, SuggSL, HoweJR, JensenCS, and WeigelRJ. (2010). Expansion of a cell population expressing stem cell markers in parathyroid glands from patients with hyperparathyroidism. Ann Surg, 251:107–113.
8.
VairaV, ElliF, FornoI, GuarnieriV, VerdelliC, FerreroS, ScillitaniA, VicentiniL, CetaniF, et al. (2012). The microRNA cluster C19MC is deregulated in parathyroid tumours. J Mol Endocrinol, 49:115–124.
9.
VerdelliC, AvaglianoL, GuarnieriV, CetaniF, FerreroS, VicentiniL, BerettaE, ScillitaniA, CreoP, et al. (2017). Expression, function, and regulation of the embryonic transcription factor TBX1 in parathyroid tumors. Lab Invest, 97:1488–1499.
VinczeS, PetersNV, KuoCL, BrownTC, KorahR, MurthaTD, BellizziJ, RiccardiA, ParhamK, et al. (2022). GCM2 variants in familial and multiglandular primary hyperparathyroidism. J Clin Endocrinol Metab, 107:e2021–e2026.
12.
NoltesME, SondorpLHJ, KrachtL, AntunesIF, WardenaarR, KelderW, KemperA, SzymanskiW, ZandeeWT, et al. (2022). Patient-derived parathyroid organoids as a tracer and drug-screening application model. Stem Cell Rep, 17:2518–2530.
13.
BinghamEL, ChengSP, Woods IgnatoskiKM, and DohertyGM. (2009). Differentiation of human embryonic stem cells to a parathyroid-like phenotype. Stem Cells Dev, 18:1071–1080.
14.
Woods IgnatoskiKM, BinghamEL, FromeLK, and DohertyGM. (2010). Differentiation of precursors into parathyroid-like cells for treatment of hypoparathyroidism. Surgery, 148:1186–1189.
15.
LawtonBR, MartineauC, SosaJA, RomanS, GibsonCE, LevineMA, and KrauseDS. (2020). Differentiation of PTH-expressing cells from human pluripotent stem cells. Endocrinology, 161:bqaa141.
16.
KanoM, MizunoN, SatoH, KimuraT, HirochikaR, IwasakiY, InoshitaN, NaganoH, KasaiM, et al. (2023). Functional calcium-responsive parathyroid glands generated using single-step blastocyst complementation. Proc Natl Acad Sci U S A, 120:e2216564120.
17.
KimJY, ParkS, OhSY, NamYH, ChoiYM, ChoiY, KimHY, JungSY, Kim HS, JoI, and JungSC. (2022). Density-dependent differentiation of tonsil-derived mesenchymal stem cells into parathyroid-hormone-releasing cells. Int J Mol Sci, 23:715.
